Joel Greenblatt Incyte Corp Transaction History

Gotham Asset Management, LLC

$9.41 Billion
Q3 2024

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Incyte Corp stock. As of the latest transaction made, Gotham Asset Management, LLC holds 65,392 shares of INCY stock, worth $4.55 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

65,392

Previous 80,137 18.4%

Holding current value

$4.55 Million

Previous $4.86 Million 11.02%

% of portfolio

0.05%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $845,330 - $1.01 Million	-14,745 Reduced 18.4%	65,392 $4.32 Million
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $7.13 Million - $8.89 Million	-139,394 Reduced 63.5%	80,137 $4.86 Million
Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $3.45 Million - $4.06 Million	60,997 Added 38.48%	219,531 $12.5 Million
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $3.87 Million - $4.76 Million	74,179 Added 87.94%	158,534 $9.95 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $3.44 Million - $3.93 Million	59,546 Added 240.02%	84,355 $4.87 Million
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $63,875 - $79,134	-1,048 Reduced 4.05%	24,809 $1.54 Million
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $986,029 - $1.21 Million	14,040 Added 118.81%	25,857 $1.87 Million
Q4 2022 Feb 14, 2023	SELL	$67.18 - $84.11 $454,069 - $568,499	-6,759 Reduced 36.39%	11,817 $949,000
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $363,923 - $455,647	5,499 Added 42.05%	18,576 $1.24 Million
Q2 2022 Aug 15, 2022	BUY	$66.18 - $83.18 $118,594 - $149,058	1,792 Added 15.88%	13,077 $993,000
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $631,877 - $762,904	-9,571 Reduced 45.89%	11,285 $896,000
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $1.11 Million - $1.29 Million	17,447 Added 511.79%	20,856 $1.53 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $61,390 - $75,113	894 Added 35.55%	3,409 $234,000
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $112,057 - $122,804	-1,403 Reduced 35.81%	2,515 $212,000
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $166,939 - $220,698	-2,196 Reduced 35.92%	3,918 $318,000
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $494,048 - $597,826	-6,119 Reduced 50.02%	6,114 $532,000
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $166,141 - $214,224	1,953 Added 19.0%	12,233 $1.1 Million
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $259,630 - $381,255	3,500 Added 51.62%	10,280 $1.07 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $2.81 Million - $3.82 Million	-44,411 Reduced 86.76%	6,780 $496,000
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $5.41 Million - $7.09 Million	-74,121 Reduced 59.15%	51,191 $4.47 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $7.33 Million - $8.7 Million	100,606 Added 407.21%	125,312 $9.3 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $904,369 - $1.09 Million	12,301 Added 99.16%	24,706 $2.1 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $266,062 - $369,079	4,186 Added 50.93%	12,405 $1.07 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $140,107 - $167,506	2,395 Added 41.12%	8,219 $523,000
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $359,632 - $432,315	5,824 New	5,824 $402,000
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $11.4 Million - $14.2 Million	-121,896 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $13.3 Million - $16.9 Million	121,896	121,896 $14.2 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account